Free Trial

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

Thermo Fisher Scientific logo
$699.98 +0.54 (+0.08%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$695.00 -4.98 (-0.71%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
4
Buy
25

Based on 29 Wall Street analysts who have issued ratings for Thermo Fisher Scientific in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 29 analysts, 4 have given a hold rating, 23 have given a buy rating, and 2 have given a strong buy rating for TMO.

Consensus Price Target

$683.64
-2.33% Downside
According to the 29 analysts' twelve-month price targets for Thermo Fisher Scientific, the average price target is $683.64. The highest price target for TMO is $810.00, while the lowest price target for TMO is $510.00. The average price target represents a forecasted downside of -2.33% from the current price of $699.98.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for TMO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Analyst Ratings Over Time

TypeCurrent Forecast
11/15/25 to 11/15/26
1 Month Ago
10/16/25 to 10/16/26
3 Months Ago
8/17/25 to 8/17/26
1 Year Ago
11/15/24 to 11/15/25
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
23 Buy rating(s)
22 Buy rating(s)
18 Buy rating(s)
18 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$683.64$657.25$621.83$601.65
Forecasted Upside-2.33% Downside-4.78% Downside6.00% Upside3.89% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

TMO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Thermo Fisher Scientific Stock vs. The Competition

TypeThermo Fisher ScientificHealthcare CompaniesBroader Market
Consensus Rating Score
2.93
2.32
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside-2.33% Downside115.11% Upside14.68% Upside
News Sentiment Rating
Positive News

See Recent TMO News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/30/2026
Argus logo
Argus
3 of 5 stars
David Toung
4 of 5 stars
Boost TargetBuy$560.00 ➝ $780.00+10.63%
10/28/2026
Evercore Inc logo
Evercore
3 of 5 stars
 Lower TargetOutperform$720.00 ➝ $615.00-11.34%
10/23/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Patrick Donnelly
4 of 5 stars
Boost TargetBuy$685.00 ➝ $800.00+18.33%
10/23/2026 DowngradeStrong-Buy ➝ Hold
10/22/2026Reiterated RatingBuy$540.00 ➝ $800.00+16.54%
10/22/2026Boost TargetSector Perform$580.00 ➝ $730.00+6.12%
10/22/2026Boost TargetOverweight$750.00 ➝ $775.00+11.67%
10/22/2026 Boost TargetBuy$720.00 ➝ $750.00+8.13%
10/22/2026 Boost TargetBuy$725.00 ➝ $750.00+8.13%
10/22/2026Boost TargetBuy$760.00 ➝ $810.00+18.52%
10/22/2026Boost TargetBuy$650.00 ➝ $775.00+11.67%
10/22/2026Boost TargetOutperform$723.00 ➝ $756.00+8.94%
10/15/2026 Initiated CoverageBuy$740.00+9.76%
10/14/2026 Boost TargetOverweight$690.00 ➝ $760.00+9.58%
10/12/2026Boost TargetOverweight$650.00 ➝ $730.00+11.10%
10/8/2026 UpgradeHold (C+) ➝ Buy (B-)
9/21/2026 Boost TargetBuy$650.00 ➝ $780.00+12.47%
9/9/2026Initiated CoverageHold ➝ Overweight$510.00-15.76%
9/9/2026 Initiated CoverageOutperform
9/9/2026 DowngradeMarket Perform
9/9/2026DowngradeOverweight ➝ Underweight
9/3/2026Initiated CoverageOutperformC$748.00
9/1/2026UpgradeHold ➝ Strong-Buy$660.00 ➝ $690.00+14.94%
7/24/2026Boost TargetMarket Perform$520.00 ➝ $575.00-17.08%
7/23/2026 Reiterated RatingBuy$585.00 ➝ $630.00+9.86%
7/22/2026 Boost TargetOutperform$600.00 ➝ $620.00-10.59%
6/2/2026Initiated CoverageOutperform$535.00+8.48%
5/26/2026 Reiterated RatingOverweight$750.00+67.10%
1/30/2026 Boost TargetOutperform$630.00 ➝ $670.00-3.29%
8/18/2025Initiated CoverageOutperform
12/13/2024 Lower TargetBuy$675.00 ➝ $660.00+26.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:00 PM ET.


Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 13, 2026. Please send any questions or comments about these Thermo Fisher Scientific pros and cons to contact@marketbeat.com.

Thermo Fisher Scientific
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

  • Thermo Fisher Scientific Inc. recently reported strong third-quarter results, beating analyst expectations with earnings per share of $6.68 against a consensus estimate of $6.40, while revenue of $12.14 billion also exceeded the projected $11.95 billion, demonstrating robust operational performance and demand for its life sciences solutions.
  • The company has demonstrated consistent revenue growth, with year-over-year revenue increasing by 9.1% in the most recent quarter and 10.5% in the second quarter of 2026, indicating that its core business segments are successfully capturing market share and driving top-line expansion.
  • Wall Street analysts maintain a positive outlook on the stock, with a consensus rating of Moderate Buy and a recent price target of $683.64, reflecting confidence in the company's long-term growth trajectory and its position as a leader in serving science.
  • Thermo Fisher Scientific Inc. offers a stable dividend yield of 0.26% with a low payout ratio of 9.92%, providing income to shareholders while retaining the majority of its earnings to reinvest in the business and fund future growth initiatives.
  • The stock has shown strong momentum, reaching a 52-week high of $727.56 in November 2026, which suggests that institutional investors and the broader market are increasingly valuing the company's strategic positioning in high-growth areas such as genomics and biopharma services.

Thermo Fisher Scientific
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

  • The current stock price of $699.98 is trading above the consensus analyst price target of $683.64, suggesting that the stock may be overvalued relative to Wall Street's average expectation for its future performance.
  • Thermo Fisher Scientific Inc. carries a high valuation with a price-to-earnings ratio of 36.92, which is significantly higher than many of its peers, meaning investors are paying a premium for earnings that may not be sustainable if growth slows down.
  • Recent insider activity has been predominantly negative, with executives including CEO Marc N. Casper and VP Lisa P. Britt selling a combined total of over 24,000 shares in the last 90 days, which can signal a lack of confidence from those closest to the company's operations.
  • The company has a debt-to-equity ratio of 0.71, indicating a moderate level of leverage that could become a burden if interest rates remain high or if the company faces unexpected operational challenges that impact its cash flow.
  • Thermo Fisher Scientific Inc. operates in a highly competitive and cyclical industry, where demand for research and development spending can fluctuate based on economic conditions, posing a risk to its revenue stability and profit margins.

TMO Forecast - Frequently Asked Questions

According to the research reports of 29 Wall Street equities research analysts, the average twelve-month stock price forecast for Thermo Fisher Scientific is $683.64, with a high forecast of $810.00 and a low forecast of $510.00.

29 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last twelve months. There are currently 4 hold ratings, 23 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TMO shares.

According to analysts, Thermo Fisher Scientific's stock has a predicted downside of -2.33% based on their 12-month stock forecasts.

Over the previous 90 days, Thermo Fisher Scientific's stock had 5 downgrades and 4 upgrades by analysts.

Analysts like Thermo Fisher Scientific more than other "healthcare" companies. The consensus rating for Thermo Fisher Scientific is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how TMO compares to other companies.


MarketBeat monitors more than a dozen sources for Thermo Fisher Scientific analyst ratings, with the most recent rating issued on 10/30/2026.
From Our Partners